Severe Acute Respiratory SyndromeNCIt concept

https://www.canada.ca/fr/sante-publique/services/rapports-publications/releve-maladies-transmissibles-canada-rmtc/numero-mensuel/2024-50/numero-6-juin-2024/depistage-sras-cov-2-infection-taux-vaccination-travailleurs-essentiels-non-soignants.html
2024
Canada
journal article
ATRX Mutation Analysis Was Not Performed
vaccination
First Degree Family History of Primary Brain Tumor Negative
Tumor Progression Absent After Initial Treatment
Has No Sibling
Chemotherapy Was Not Administered as an Additional Treatment for a New Tumor Event
Targeted Molecular Therapy Was Not Administered as an Additional Treatment for a New Tumor Event
Adjuvant I-131 Therapy Negative
No History of Non-Cardiac Surgery
Adjuvant Post-operative Immunological Therapy Was Not Administered
Additional Molecular Studies Were Not Performed
Chemotherapy Not Received
Infection
ROS1 Rearrangement Analysis Was Not Performed
Genetic Screening
Intercurrent Illness is Absent at Onset of Chief Complaint
Severe Acute Respiratory Syndrome
Additional Surgery for New Metastatic Tumor Event Was Not Performed
Norway
No History of Gestational Complication
Preoperative IV Antiemetics were not Administered
Other Preoperative IV Medications were not Administered
No Response to Intervention for Kawasaki Disease
Radiation Was Not Administered as an Additional Treatment for a New Tumor Event
mass screening
Regular Smokeless Tobacco Use for Six Weeks or More Negative
Nitric Oxide Measurement
History of Medical Treatment Absent
EGFR Amplification Analysis Was Not Performed
Peripheral Blood Immunophenotyping and Cytochemistry Were Not Performed
Any Metastatic Diagnosis Absent
Characteristic
Preoperative IV Antacids were not Administered
Minor Criteria for Rheumatic Heart Disease Not Present
Lymph Node Dissection Was Not Performed
PTEN Mutation Analysis Was Not Performed
preventive immunization/medication
Fluorescence In Situ Hybridization Was Not Performed
Preoperative IV Opiates were not Administered
Neither Case or Control Status
ERBB2 Mutation Analysis Was Not Performed
SARS Coronavirus
Routine Cytogenetics Were not Completed
SDH Complex Mutation Analysis Was Not Performed
Severe acute respiratory syndrome-related coronavirus
screening
First Degree Family History Cancer Negative
Trial Screening
Caffeine Not Routinely Consumed
Radiation History Negative
Evidence of Disease Absent after Completion of Therapy
ATRX Gene Mutation Negative
Hormone Therapy Was Not Administered as an Additional Treatment for a New Tumor Event
Adjuvant Post-operative Targeted Molecular Therapy Was Not Administered
TP53 Mutation Analysis Was Not Performed
vaccination
No History of Congenital Heart Disease
Additional Immunohistochemistry Was Not Performed
BRAF Rearrangement Analysis Was Not Performed
Screening Study
Chief Complaint Not Caused by Trauma
Multiple Known Primary Tumors Absent at Initial Melanoma Diagnosis
Radiation Therapy Not Received
Site Screening
Documentation Absent
Patient was Not Previously Evaluated for Current Chief Complaint
BRAF Mutation Analysis Was Not Performed
Subsequent Known Primary Melanoma(s) Not Found During the Follow-Up
MGMT Promoter Methylation Testing Was Not Performed
Therapeutic Ionizing Radiation to Head History Absent
1p/19q Deletion Analysis Was Not Performed
Intervention Not Given for Kawasaki Disease
Preoperative IV Sedation was Not Administered
Chief Complaint was Not Witnessed
Substance Screening
NF1 Mutation Analysis Was Not Performed
Additional Surgery for New Loco-Regional Tumor Event Was Not Performed
Unemployed
Adjuvant Post-operative Radiation Therapy Was Not Administered
Regional Anesthesia was not Administered
Adjuvant Post-operative Chemotherapy Was Not Administered
New Disease is not Multifocal
MET Mutation Analysis Was Not Performed
Interferon Gamma Treatment was not Administered 90 Days Prior to Specimen Resection
Paraneoplastic Syndrome is Not Present
RET Rearrangement Analysis Was Not Performed
No Known History of Alcohol Use
EGFR Gene Amplification Negative
Local Anesthesia Agents were not Administered
IDH Family Wildtype
Family History of Stomach Cancer Absent
IDH Family Mutation Analysis Was Not Performed
infectious disease, nos
Another Form of Birth Control was not Used
Cancer History Absent
History of Colorectal Cancer Negative
EGFR Mutation Analysis Was Not Performed
KRAS Mutation Analysis Was Not Performed
PDGFRA Mutation Analysis Was Not Performed
First Degree Family History Thyroid Cancer Negative
No History of Rheumatic Fever
No History of Myopathy
Vaccination
10q23/PTEN Locus Deletion Analysis Was Not Performed
Last Screening
Use of Smokeless Tobacco at Time of Diagnosis Negative
Adverse Event Associated with Infection
Neither
No History of Neonatal Complication
Human Cells, Tissues, and Cellular and Tissue-Based Products Screening
caregivers
Eligibility Determination
New Tumor Event After Initial Treatment Absent
Not Lost to Follow-Up
PTEN Gene Mutation Negative
has provider
Interferon Gamma Treatment was not Administered Prior to Specimen Resection
Bone Marrow Aspirate Immunophenotyping and Cytochemistry Were Not Performed
vaccination, nos
Physician Diagnosed Diabetes Absent
NON Mouse
Immunotherapy Was Not Administered as an Additional Treatment for a New Tumor Event
NRAS Mutation Analysis Was Not Performed
Additional Surgery for New Tumor Event Absent
No Known History of Illicit Drug Use
Adjuvant Post-operative Pharmaceutical Therapy Was Not Administered
ALK Rearrangement Analysis Was Not Performed
IV Anesthesia was not Administered
Cancer Screening
Medication Not Taken
Patient was not Postmenopausal with no Prior Oophorectomy
Nitric Oxide
No History of Other Muscular Dystrophy or Glycogen Storage Disorder
KIT Mutation Analysis Was Not Performed
Chemical/Occupational Exposure Absent
Tumor Reoccurrence Absent After Initial Treatment
Negation
No History of Kawasaki Disease
Hypertension Absent

---